Send mail to Author

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus : a randomized, placebo-controlled phase II AIO trial with serum biomarker program (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _      ___      ____       ___      _  __   __   __  
| || | ||   / _ \\   |  _ \\    / _ \\   | |/ //  \ \\/ // 
| '--' ||  | / \ ||  | |_| ||  / //\ \\  | ' //    \ ` //  
| .--. ||  | \_/ ||  | .  //  |  ___  || | . \\     | ||   
|_|| |_||   \___//   |_|\_\\  |_||  |_|| |_|\_\\    |_||   
`-`  `-`    `---`    `-` --`  `-`   `-`  `-` --`    `-`'
 


Back to frontdoor view

OPUS4 Logo